You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

LOSARTAN POTASSIUM Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Losartan Potassium, and when can generic versions of Losartan Potassium launch?

Losartan Potassium is a drug marketed by Aiping Pharm Inc, Alembic Pharms Ltd, Apotex, Apotex Corp, Aurobindo Pharma, Chartwell Rx, Granules, Hetero Labs Ltd V, Hikma, Hisun Pharm Hangzhou, Ipca Labs Ltd, Jubilant Cadista, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, MSN, Mylan, Prinston Inc, Strides Pharma, Teva, Torrent Pharms, Unichem, Watson Labs, Zydus Pharms Usa Inc, Sandoz, and Teva Pharms. and is included in forty-one NDAs.

The generic ingredient in LOSARTAN POTASSIUM is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for LOSARTAN POTASSIUM?
What are the global sales for LOSARTAN POTASSIUM?
What is Average Wholesale Price for LOSARTAN POTASSIUM?

Summary for LOSARTAN POTASSIUM

US Patents:	0
Applicants:	26
NDAs:	41
Finished Product Suppliers / Packagers:	46
Raw Ingredient (Bulk) Api Vendors:	139
Clinical Trials:	86
Patent Applications:	2,491
Drug Prices:	Drug price information for LOSARTAN POTASSIUM
Drug Sales Revenues:	Drug sales revenues for LOSARTAN POTASSIUM
DailyMed Link:	LOSARTAN POTASSIUM at DailyMed

Drug patent expirations by year for LOSARTAN POTASSIUM

Drug Prices for LOSARTAN POTASSIUM

Recent Clinical Trials for LOSARTAN POTASSIUM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Gadjah Mada University	Phase 1/Phase 2
Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Massachusetts General Hospital	Early Phase 1

See all LOSARTAN POTASSIUM clinical trials

Pharmacology for LOSARTAN POTASSIUM

Drug Class	Angiotensin 2 Receptor Blocker
Mechanism of Action	Angiotensin 2 Receptor Antagonists

Medical Subject Heading (MeSH) Categories for LOSARTAN POTASSIUM

Angiotensin II Type 1 Receptor Blockers
Anti-Arrhythmia Agents
Antihypertensive Agents

Anatomical Therapeutic Chemical (ATC) Classes for LOSARTAN POTASSIUM

C09CA	Angiotensin II receptor blockers (ARBs), plain
C09C	ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C	Cardiovascular system

US Patents and Regulatory Information for LOSARTAN POTASSIUM

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Pharms Usa Inc	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	078243-003	Oct 6, 2010	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; losartan potassium	TABLET;ORAL	091652-002	Apr 6, 2010		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Macleods Pharms Ltd	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	202230-002	May 30, 2012	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ipca Labs Ltd	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	200290-002	Aug 30, 2013	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hikma	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; losartan potassium	TABLET;ORAL	077732-001	Apr 6, 2010		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Torrent Pharms	LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; losartan potassium	TABLET;ORAL	090528-002	Oct 6, 2010		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.